Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 28 articles PubMed · modèle : gemma4:31b
Résumé
Chamomile is an ancient medicinal herb used for its anti-inflammatory, sedative, and antioxidant properties [PMID:36297396, PMID:21132119].
Contexte
Chamomile is a member of the Asteraceae/Compositae family, primarily represented by two varieties: German chamomile (Matricaria chamomilla L. or Matricaria recutita) and Roman chamomile (Chamaemelum nobile L. or Anthemis nobilis) [PMID:36297396, PMID:21132119, PMID:31643492].
Usages traditionnels
Traditionally used as a sedative, mild analgesic, sleep medication, and for gastrointestinal conditions [PMID:31643492]. It has been used for hay fever, inflammation, muscle spasms, menstrual disorders, insomnia, ulcers, wounds, rheumatic pain, and hemorrhoids [PMID:21132119].
Composés actifs
Key components include flavonoids (apigenin, luteolin, quercetin, patuletin), terpenoids (alpha-bisabolol, farnesene), sesquiterpenelactones (chamazulene, matricin), and coumarins [PMID:36297396, PMID:31643492, PMID:16628544].
Mécanisme d'action
Chamomile exhibits anti-inflammatory, antioxidant, and antimicrobial activities [PMID:36297396, PMID:16628544]. In animal models, chamazulene has shown interactions with stress-related targets including IFN-γ, IL-6, caspase-3, BDNF, and GLUT-1 [PMID:41351710].
Preuves cliniques
Preuve AGeneralized Anxiety Disorder (GAD)
Significant improvement in GAD symptoms was observed after 2 and 4 weeks of treatment [PMID:31006899]; one trial showed a significantly greater reduction in HAM-A scores compared to placebo [PMID:19593179].
Preuve BDiabetic Neuropathy
Topical chamomile oil was evaluated as a therapeutic intervention to improve neuropathy indices [PMID:40440968].
Preuve BDepression, Anxiety, and Stress (Older Adults)
Inhalation aromatherapy using lavender and chamomile essential oils resulted in statistically significant improvement [PMID:33454232].
Preuve CPremenstrual Syndrome (PMS)
Chamomile is used for PMS relief due to its anti-inflammatory effects [PMID:31970017].
Preuve AInsomnia and Sleep Quality
A meta-analysis of one RCT found no significant change in insomnia severity index [PMID:31006899].
Preuve DSARS-CoV-2
Sécurité et effets indésirables
Chamomile has not been implicated in causing clinically apparent liver injury or serum enzyme elevations [PMID:31643492]. Some species in the Compositae family are suspected of causing allergic contact dermatitis, though sensitization occurs rarely with German chamomile [PMID:12492516]. Roman chamomile ingredients used in cosmetics are generally not irritating or sensitizing [PMID:28553737].
Synthèse des preuves
Evidence is strongest (Level A) for the treatment of Generalized Anxiety Disorder, while evidence for insomnia is limited and non-significant. Many other claims (anti-inflammatory, antimicrobial) are supported by reviews or animal models (Level C/D) rather than large-scale human trials.
Sources PubMed
1.PMID: 36297396 (2022) — A Comprehensive Study of Therapeutic Applications of Chamomile. · Pharmaceuticals (Basel, Switzerland)
2.PMID: 31643492 (2012) — Chamomile: A Review of Its Traditional Uses, Chemical Constituents, Pharmacological Activities and Quality Control Studies. · Molecules (Basel, Switzerland)
3.PMID: 16628544 (2006) — A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). · Phytotherapy research : PTR
4.PMID: 21132119 (2010) — Chamomile: A herbal medicine of the past with bright future. · Molecular medicine reports
5.PMID: 33454232 (2022) — The effects of Lavender and Chamomile essential oil inhalation aromatherapy on depression, anxiety and stress in older community-dwelling people: A randomized controlled trial.
Sources gouvernementales
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
In vitro results show a significant inhibition of SARS-CoV-2 by chamomile decoction [PMID:40230940].
· Explore (New York, N.Y.)
6.PMID: 27912875 (2016) — Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial. · Phytomedicine : international journal of phytotherapy and phytopharmacology
7.PMID: 31006899 (2019) — Therapeutic efficacy and safety of chamomile for state anxiety, generalized anxiety disorder, insomnia, and sleep quality: A systematic review and meta-analysis of randomized trials and quasi-randomized trials. · Phytotherapy research : PTR
8.PMID: 19593179 (2009) — A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. · Journal of clinical psychopharmacology
9.PMID: 35926778 (2022) — Anxiolytic effect of Anthemis nobilis L. (roman chamomile) and Citrus reticulata Blanco (tangerine) essential oils using the light-dark test in zebrafish (Danio rerio). · Journal of ethnopharmacology
10.PMID: 40230940 (2024) — Chamomile in combating SARS-Cov-2. · Bioinformation
11.PMID: 40374153 (2025) — Chamomile: A systematic review of adverse events. · Complementary therapies in medicine
13.PMID: 41599305 (2026) — Unlocking the Secrets of Roman Chamomile (Anthemis nobilis L.) Essential Oil: Structural Elucidation and Acute Toxicity of New Esters. · Molecules (Basel, Switzerland)
14.PMID: 40440968 (2025) — Topical chamomile oil as a novel therapeutic intervention for diabetic neuropathy: A randomized double-blind controlled clinical trial. · Explore (New York, N.Y.)
15.PMID: 28553737 (2017) — Safety Assessment of Anthemis nobilis-Derived Ingredients as Used in Cosmetics. · International journal of toxicology
16.PMID: 40665590 (2025) — Anti-inflammatory effect of chamomile from randomized clinical trials: a systematic review and meta-analyses. · Pharmaceutical biology
17.PMID: 38240454 (2024) — Evaluation of the use of chamomile in isolation and in association with laser photobiomodulation in the healing of rats oral mucosa. · Photochemistry and photobiology
18.PMID: 37052390 (2023) — Effect of Chamomile on the Complications of Cancer: A Systematic Review. · Integrative cancer therapies
19.PMID: 41351710 (2025) — Chamomile Modulates Glucose Metabolism and Neuro-inflammation to Alleviate Stress-Induced Depression in Mice. · Molecular neurobiology
20.PMID: 34602925 (2021) — Chamomile as a potential remedy for obesity and metabolic syndrome. · EXCLI journal
21.PMID: 39836709 (2025) — Efficacy and safety of Matricaria chamomilla intervention in managing menopausal symptoms: a triple-blind clinical trial. · Menopause (New York, N.Y.)
22.PMID: 31970017 (2019) — Efficacy of Chamomile in the Treatment of Premenstrual Syndrome: A Systematic Review. · Journal of pharmacopuncture
23.PMID: 41190721 (2025) — Chemometrically-supported quality assessment of chamomile tea. · Acta pharmaceutica (Zagreb, Croatia)
24.PMID: 21156115 (2010) — [Evidence of dermatological effects of chamomile]. · Ugeskrift for laeger
25.PMID: 12492516 (2002) — Contact sensitization from Compositae-containing herbal remedies and cosmetics. · Contact dermatitis